Friday, August 15, 2014

Ebola Virus [Ebola virus disease (EVD) or Ebola hemorrhagic fever (EHF) ]

What is Ebola?

Ebola is a virus which causes rare but deadly disease Ebola virus disease (EVD) or Ebola
hemorrhagic fever (EHF) which is a disease of humans and other primates. Symptoms start two days to three weeks after contact with the virus. Symptoms area fever, sore throat, muscle pain, and headaches. Typically nausea, vomiting, and diarrhea follow, along with decreased functioning of the liver and kidneys. Around this time, affected people may begin to bleed both within the body and externally.
Ebola’s natural reservoir is unknown.Non human primates have been the source of human infections but are not thought to be the reservoirs.

Ebola Taxonomy or Scientific Classification
Order: Mononegavirales
  Family: Filoviridae
  Genus: Ebola like viruses
  Species: Ebola 

Subtypes  
Ebola-Zaire, Ebola-Sudan,Ebola-Ivory Coast-disease in humans
Ebola-Reston-disease in nonhuman primates

Filoviridae or “Filoviruses”
          Most mysterious virus group
          Pathogenesis poorly understood
          Ebola
        Natural history/reservoirs unknown
        Exist throughout the world
        Endemic to Africa
        Filamentous ssRNA- (antisense) viruses
History
Named after the Ebola River in the Democratic Republic of the Congo (formerly Zaire), near the first epidemics.
Two species were identified in 1976:
  • Zaire ebolavirus (ZEBOV)
  • Sudan ebolavirus (SEBOV)
Case fatality rates of 83% and 54% respectively.
A third species, Reston ebolavirus (REBOV), was discovered in November 1989 in a group of monkeys (Macaca fascicularis) imported from the Philippines.
Ivory Coast ebolavirus – Only one case. Unlucky scientist.

Outbreaks of EBOLA

Most Recent Incident
April 25 – June 16 2005 total of 12 cases including 9 deaths were reported in Etoumbi and Mbomo in the Cuvette Quest Region


Ebola Pathogenesis
          Enters Bloodstream
         Skin, membranes, Open wounds
          Cell Level
         Socks with cell membrane
          Viral RNA
        Released into cytoplasm
        Production new viral proteins/ genetic material
           New viral genomes
        Rapidly coated in protein
        Create cores
          Viral cores
        Stack up in cell
        Migrate to the cell surface
        Produce trans-membrane proteins
        Push through cell surface
        Become enveloped by cell membrane
          ssRNA- Genome Mutations
        Capable of rapid mutation
        Very adaptable to evade host defenses and environmental change
          Theory
         Virus evolved to occupy special niches in the wild

Modes of Transmission
There are 3 modes of infection
  1. Unsterilized needles
  2. Suboptimal Hospital conditions
  3. Personal contact
Symptoms and Diagnostic Tests



          Early symptoms
        Muscle aches, fever, vomiting
        Red eyes, skin rash, diarrhea, stomach pain
        Acute symptoms
        Bleeding/hemorrhaging from skin, orifices, internal organs
        Onset of fever.
        Intense weakness.
        Muscle Pain.
        Headache.
        Soar Throat.
        Vommitting, Diarrhoea.
        Impaired Kidnay and liver function
          Early Diagnosis
          Very difficult
          Signs & symptoms very similar to other infections
          Laboratory Test for the diagnosis of Ebola Virus
          PCR detection
          ELISA (enzyme-linked immuno-absorbant) assay

Is there a cure for Ebola?
          There are no known curative medications for Ebola.
          However, there have been very recent developments in preventative medications.
          No Standard Treatment available
          Patients receive supportive therapy
          Treating complicating infections
          Balancing patient’s fluids and electrolytes
          Maintaining oxygen status and blood pressure
          No vaccines!
          Patients are isolated
          Medical Staff Training
          Western sanitation practices
          Intake
          Care during stay
          After patient dies
          Infection-control Measures
          complete equipment and area sterilization

Vaccines
          In June, Jones and his colleagues, Dr. Heinz Feldmann of Winnipeg and Dr. Thomas Geisbert at Fort Detrick, Maryland announced that they had successfully vaccinated monkeys against the deadly Ebola virus
          The Ebola vaccine is based on the 1976 strain of the Zaire species and protects from the 1995, but not the other 2 species that affect humans.

Risk of Bioterrorism?
Airborne transmission of Ebola Zaire has been demonstrated in monkeys in a controlled laboratory experiment
Plum Island…?

Prevention
After Death
Virus contagious in fluids for days
          Burial use extreme caution
        Handling and transport
        Cultural practices/ religious belief
        Incinerate all waste!!!!
        Protective clothing
        Body sealed in body bag and coffin
        Sanitation of all equipment before and after
        Risk for exposure special steps need to be taken to protect the family and community from illness.
        Family only
        Why open casket not possible
        Some practices cannot be done
Conclusion
          Reservoirs in Nature
        Largely unknown
        Possibly infected animals (primates?)
          Transmission
        Direct contact blood/secretions of infected person
        Possible airborne (Reston primate facility)
          Onset of illness abrupt
        Incubation period:  2 to 21 days
        Infections are acute and mostly deadly

Latest Morbidity and Mortality Reports
Ebola-Reston Virus Infection Among Quarantined Nonhuman Primates -- Texas, 1996
Report describes death and blood testing of cynomolgus monkey imported from the Philippines held in a private quarantine facility in Texas
          Outbreak of Ebola Hemorrhagic Fever ---Uganda, August 2000--January 2001
        Report describes surveillance and control activities related to the EHF outbreak
        Presents preliminary clinical and epidemiologic findings

Ebola Information Posters
Ebola Virus

Ebola Virus

Ebola Virus

Ebola Virus

Ebola Virus

Ebola Virus
Ebola Virus

Wednesday, March 5, 2014

Chronic inflammation

What is Chronic Inflammation:
Inflmmation of prolonged duration in which inflmmation, tissuue injury and attempts at repair coexist, in varying combinations.

  1. Chronic Suppurative on acute: 
  2. Chronic granulomatus: (Initiates without an acute phase)
Suppurative in type:
Abscesses
  • Inadequate or delayed drain leads to thick fibrous wall    formation.                                         
  • The residual bacteria get reactivated
  • Pus formation.   
  • Presence of foreign material or indigestible dead tissue.
Eg: Osteomyelitis, damaged Collagen

Chronic inflammation
Follow acute inflammation
Persistence of the stimulus
Disturbance to the healing process
ŸRepeated bouts of acute inflammation and healing in between.
Low grade persistent infection.    

Causes
  • Microorganisms where body can mount limited immune reactions
  • Impaired Sequelae of an acute inflammation
  • Foreign bodies
  • body defense
  • Immune reactions


Chronic inflammation without an acute phase
Infection: TB, Leprosy, Syphilis
Immunological: Rheumatoid arthritis Ulcerative colitis Crohn’s disease
Poor blood supply (leg ulcer)

Chronic inflammatory lesions
May vary histologically according to causative agent
However there is a set of morphological features in common.  

Histologically
  • Infiltration by mononuclear cells
  • Macrophages
  • lymphocytes
  • plasma cells
  • Proliferation of blood vessels/fibrosis (angiogenesis)
  • Fibrosis
  • Tissue destruction (induce by inflammatory cells)  
 
Mononuclear phagocytic system
Blood monocyte:
Macrophages (at extra vascular tissue) 
Tissue macrophages (Scattered in connective tissue or concentrated in organs)
Eg: Kupffer cells in Liver                                                                                                   
Sinus histiocytes in lymph nodes
Alveolar macrophages in lung
Osteoclasts in bones
Microglia (CNS)

Monocytes
Migration
Morphological transformation (macrophages and giant cells)
Activation
Secretion of biologically active products


Cells types present
  • Macrophages            Ÿ 
  • Eosenophils
  • Mast cells                 
  • ŸLymphocytes

Existence of CI, AI and repair
  • Macrophages persist at the site (Due to the influence of chemical mediators)
  • Destruction of invading microorganisms /normal tissues
  • Secretion of chemical mediators by macrophages
  • Functions of them,
  • Proliferation of fibroblasts, Laying down of collagen
  • Angiogenesis, Activation of lympho macrophages
  • ŸDead and dieing leukocytes/necrotic tissues helps in developing acute inflammation  
Granulomas /Granulomatus infection
  • Chronic inflammatory lesion in the form of mass.
  • Collection of macrophages or modified macrophages (epitheliod / giant cells)
  • Granulomas /Granulomatus infection
  • A granuloma is a focal area of granulomatus inflammation.
  • Consist of macrophage aggregation
  • Epithelial cell transformation
  • Collar of lymphocytes
  • Appearance giant cells and of fibrosis can see with the time 
    
Eg: 
  • TB
  • Sarcoidosis
  • Cat scratch disease
  • Leprosy
  • Syphilis
  • Mycotic infections
Two types of granulomas: Base on pathogenesis
Foreign body type:
Form around foreign bodies

Immune type: When the foreign practical are capable of induce cell mediate immune responses
(but not always granulomas will develop)

Definition
Granulomas is a result of chronic inflammatory reaction containing a collection of cells of monocytic series arrange in a compact mass.

Cells
Macrophages
Epithelioid cells
Giant cells: Langhans giant cells
Foreign body type giant cells  

Accumulation of macrophages
Under the influence of chemotaxis
C5a, fibrinopeptides, cationic proteins
Lymphokines :
PDGF, TGF(beta)
products of collagen brake down

By mitotic division 
Immobilization and prolong survival  (if the irritants are low virulent )

Tuberculosis:
Chronic disease common worldwide.
Causes a characteristic granulomatous inflammation
Inability of the neutrophils to kill the micro organisms due to lipoprotein coating.


Mycobacterium tuberculosis.
Hominis (lungs)                                                
Bovis (Tonsils, Intestine) 


Spread
  • Droplet from patients (weeks or months)
  • Conjunctiva
  • Punctures
  • However need sustain contact than casual contact.

Tissue damage 
MT has no Endotoxins
Exotoxins 
Histiolitic enzymes

Development of immune response against outer coat of the organism.

Tuberculin test
2 to 4 weeks after infection : + Tuberculin test
PPD (purified protein derivative)
(Culture in which TB is grown)
Induration More that 5.mm within 48 hours.
Positivity indicates infection but not the disease.

Primary Tuberculosis
Occurs in individuals who have never previously been infected with M. tuberculosis (childhood infection if TB is common, adult life if uncommon)

Usually caused by inhalation of the organisms or rarely by ingestion of the organism.

Primary infection
Lungs             Hilum
Tonsils           neck nodes
Intestine         mesentery

Primary Tuberculosis
In respiratory system, inhalation of the organisms cause a subpleural lesion usually in the lower part of the upper lobe or upper part of the lower lobe. This is called Ghon focus.

Location is in these sites is because bacterium is a strict aerobe and prefers these well oxygenated regions

Ghon’s focus
When the tissue is invaded by the mycobacteria there is no hypersensitivity reaction. Instead there is acute, non specific inflammatory response with predominant neutrophils.

This is followed by macrophages which ingest the bacilli and present Ags to to T lymphocytes leading to proliferation of a clone of T cells .

The emergence of specific hypersensitivity lead to release of lymphokines,that attract more macrophages.

These accumulate to form the characteristic granuloma.

Ghon focus
Usually single
1 to 2 cm
Location –Beneath pleura- mid zone of the lung 

Microscopic appearance

Primary complex
Tubercle bacilli, either free or contained in macrophages, may drain to the  regional lymph nodes and set up granulomatous inflammation, causing massive lymph node enlargement.

The combination of the Ghon focus, draining lymphatics and the regional lymph nodes is called the primary complex.


Calcification of the lymph nodes
Sequelae of primary complex
Healing  with small fibrous scar replacing caseous necrosis. Lesion will be walled off.
Calcification
Reactivation of infection later when host defences become lowered.
plural effusion
Enlarged caseous nodes can obstruct bronchi, leading to collapse, retention of secretion and inflammatory consolidation

Caseous node erodes into a bronchi  with satellite lesions in lungs (TB bronchopneumonia).

Eroding into a pulmonary vein causing generalised milliary TB.

Erosion into pulmonary artery leads to miliary TB of lungs

TB bronchopneumonia
Opening of the caseous node to a bronchus.
Air bone infection
TB bronchopneumonia
(Multiple pneumonic patches arrangeed in and around terminal bronchi)
The lesions spread rapidly and accumulate macrophages and lymphocytes followed by necrosis 

Necrotic patches get enlarged and discharged which will lead to dissemination and cavitations. (no fibrous walls)
Pneumothorax
TB bronchopneumonia can happen after both 1ry and 2ry TB.  

Rapidly spreading tuberculous bronchopneumonia: debilitated by intercurrent disease, diabetes, malnutrition etc.
Acute miliary tuberculosis of the lungs due to blood stream spread to lungs. Grey tubercles visible to naked eye 3mm in diameter. More numerous and larger in upper lobes than lower lobes. Microscopically these are ill formed and often giant cells are absent. Usually these lesions do not cavitate

Effects on the other organs of the body
Miliary tuberculosis due to systemic spread to kineys, spleen, brain, liver etc.
Tuberculous ulcers in the intestine  due swallowed sputum.
Tuberculosis of larynx due to direct spread from sputum.
Secondary amyloidosis.

Miliary TB
Common with 1ry TB
Due to involvement of veins
Multiple scatted tubercles
Not well developed/uniform in size
1-2 mm
Some times without giant cells (necrosis)


Secondary  Tuberculosis (Post primary)
Infection may me exogenous or endogenous
After active primary infection
Reactivation asymptomatic primary lesions:
Malnutrition,
Severe illness,
Intercurrent lung infection,
Systemic immunosuppression
Exogenous: caused by inhaled organisms

Immunity
During primary tuberculosis or during BCG immunisation, the patient develops cell mediated immunity to antigens of tubercle bacillus.
This is demonstrated by skin test (Mantoux) test
Immunity is associated with increased resistance to subsequent infection.

Re infected lesions:
Apex of the lungs
Endogenous infections (swallowing sputum) 
Metastatic lesions are similar to re-infected
Lesions
Large in size (spread locally) no lymph node involvement

Cavity formation
Caseous material discharge gradually leaving a small cavity.
Cavities can become very large with overgrowth of fibrous tissue.
Cavity walls are irregular with raised bands representing obliterated blood vessels.
The surface is lined by caseous material or by pus and debris mixed with blood.
If the disease is inactive the wall becomes very smooth


In early cases the lesions are often in the apices of the lungs
In advanced cases there may be more than one cavitatory lesion.
All the lesions are distributed in the upper part of the lungs
Caseation may involve the wall of a bronchus leading to obstruction of the lumen.

Sequelae of tuberculous cavities
Local effects
Due to fibrosis lung tissue shrinks causing bronchiectasis (upper lobe bronchiectasis)
Blood vessels  can become weaken and rupture leading to haemoptysis
Aneurysm formation- called Rasmoussen’s aneurism leading to fatal haemorhage.
Fungal infections can be localized in these cavities.


Tuberculosis                 
Primary
Seen in non immune people.
Usually childhood cases
Subpleural mid zone

Lymph nodes are always involved
Seen in immune people

Secondary
Often adults
Lung apices

Lymph nodes are not always involvecd



Popular Posts

Join This site